Intraoperative transcranial doppler ultrasound in head and neck surgery: A preliminary report

Nosan, David K.; Gomez, Camilo R.; Boyd, James H.; Boone, K. E.; Maves, Michael D.

doi:10.1016/s0196-0709(98)90121-1

Cited by 2 publications

(1 citation statement)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…18 It is also possible that a stroke may occur during neck dissection that may be related to preexisting atherosclerosis in the carotid system; this is an infrequent complication, however, and is related more to preoperative positioning issues and preexisting vascular disease than to age. 19 Finally, the use of any aggressive treatment modality must be tempered with a thorough evaluation for comorbidities as well as consideration of the desires of the patients and their families. A recent report in Cancer 1 emphasizes that cancer may represent a natural end to life, or what the Japanese authors call Tenju-gann.…”

Section: Evidence Advocating the Modification Of Treatment Regimens Fmentioning

confidence: 99%

Treatment of Stage III and IV Supraglottic Carcinoma

Bumpous

1999

Arch Otolaryngol Head Neck Surg

View full text Add to dashboard Cite

Hypothesis:The treatment of a T3, N1, M0 supraglottic carcinoma should be the same in an otherwise healthy 80-year-old patient as in an otherwise healthy 40-year-old patient.Otolaryngologists are increasingly faced with challenges presented by the "graying" of our patient population. The fastest growing element of our population comprises individuals who are older than 65 years. Furthermore, the proportion of deaths due to cancer in the aged has been increasing in developed countries, including the United States. 1 There has been debate among oncologists regarding the need to modify aggressive treatment protocols with regard to patient age. The intention of this article is to bring into focus the impact of aging on the treatment of locoregionally advanced squamous cell carcinoma of the supraglottic larynx. LONGEVITYIt is pertinent to examine longevity, or life expectancy, when considering the treatment of supraglottic cancer in elderly vs younger patients. According to the Statistical Abstract of the United States 1997, 2 the average 80-year-old person in the United States has a life expectancy of 8.3 years. Further categorization indicates that life expectancy is also influenced by sex and ethnicity. An 80-year-old white man has a life expectancy of 7.2 years, whereas an 80year-old white woman has an expectancy of 9.0 years. The life expectancy of an 80-year-old Afri-can American man and an 80-yearold African American woman is 6.8 and 8.6 years, respectively. 2 The fact that the average octogenarian can expect his or her life to be measured in a significant number of years, rather than days, weeks, or months would seem to mitigate a noninterventional approach regarding cancer.

show abstract

Section: Evidence Advocating the Modification Of Treatment Regimens Fmentioning

confidence: 99%